Q2 2024 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2024-08-14 · accession 0001104659-24-089642
$1.65B
Reported value
63
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $187.5M | 11.3% | 1,021,078 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $105.1M | 6.35% | 10,595,089 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $92.3M | 5.58% | 4,423,616 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $63.8M | 3.86% | 4,721,054 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $59.2M | 3.58% | 4,889,554 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $53.5M | 3.23% | 4,569,802 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $51.0M | 3.08% | 929,506 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $50.1M | 3.03% | 5,562,096 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $48.3M | 2.92% | 15,269,217 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $47.1M | 2.85% | 1,579,275 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $45.4M | 2.75% | 5,453,083 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $44.3M | 2.68% | 5,211,037 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $43.2M | 2.61% | 13,169,057 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $40.5M | 2.45% | 4,799,973 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $39.9M | 2.41% | 1,703,061 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $38.3M | 2.31% | 2,014,296 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $37.9M | 2.29% | 1,614,473 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $37.7M | 2.28% | 1,087,576 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $36.9M | 2.23% | 1,013,663 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $34.5M | 2.09% | 3,209,591 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $33.5M | 2.02% | 595,570 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $31.5M | 1.90% | 6,427,462 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $30.1M | 1.82% | 390,253 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $26.7M | 1.61% | 759,516 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $26.6M | 1.61% | 718,723 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $25.4M | 1.54% | 8,253,316 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $25.2M | 1.53% | 552,506 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $24.3M | 1.47% | 4,036,451 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $22.5M | 1.36% | 1,073,435 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $21.7M | 1.31% | 5,615,489 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $21.1M | 1.28% | 3,072,478 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $19.0M | 1.15% | 720,177 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $17.7M | 1.07% | 39,843 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $14.4M | 0.87% | 16,380,327 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $14.0M | 0.85% | 1,745,656 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $13.9M | 0.84% | 1,881,501 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $13.4M | 0.81% | 39,483 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $10.7M | 0.64% | 2,074,350 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $10.2M | 0.62% | 94,405 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $9.7M | 0.59% | 213,024 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $8.9M | 0.54% | 3,031,009 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $8.0M | 0.48% | 560,971 | Common | SOLE |
| H00263105 | ACIU | AC IMMUNE SA | $7.2M | 0.44% | 1,807,704 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $7.1M | 0.43% | 1,463,406 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $6.4M | 0.39% | 1,942,555 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.1M | 0.37% | 111,867 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $5.0M | 0.30% | 2,164,126 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $4.0M | 0.24% | 1,034,583 | Common | SOLE |
| 046513206 | ATRA | ATARA BIOTHERAPEUTICS INC | $3.8M | 0.23% | 452,270 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $3.8M | 0.23% | 2,108,219 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.7M | 0.23% | 2,074,372 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $3.4M | 0.20% | 3,065,714 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $3.3M | 0.20% | 442,826 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $3.2M | 0.19% | 5,107,732 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $3.1M | 0.19% | 3,077,828 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2.4M | 0.14% | 1,046,587 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.6M | 0.10% | 536,682 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $1.4M | 0.08% | 1,907,969 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.3M | 0.08% | 1,608,089 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $728,587 | 0.04% | 411,631 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $697,645 | 0.04% | 715,607 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $629,538 | 0.04% | 1,063,769 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $211,677 | 0.01% | 154,509 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.